SCHEMBL6592124

SCHEMBL6592124

CN(C)S(=O)(=O)N(C)Cc1csc(C(=O)Nc2c(OCC3CO3)cc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c1Cl

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
F2 P00734 20/20 0.70
F10 P00742 16/20 0.70
KLKB1 P03952 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6593197 0.94 F2 (0.80) F2F10KLKB1
SCHEMBL6588643 0.89 F2 (0.88) F2F10KLKB1
SCHEMBL6596457 0.86 F2 (0.72) F2F10KLKB1
SCHEMBL6589942 0.83 F2 (0.65) F2F10
SCHEMBL6590139 0.83 F2 (1.00) F2F10KLKB1
SCHEMBL6590494 0.82 F2 (0.83) F2F10KLKB1
SCHEMBL6603437 0.80 F2 (0.84) F2F10KLKB1
SCHEMBL6593288 0.80 F2 (0.76) F2F10
SCHEMBL6590864 0.80 F2 (0.82) F2F10KLKB1
SCHEMBL6590183 0.80 F2 (0.86) F2F10KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed